Answers are grounded in this paper and cite their sources.
BACKGROUND: Quantitative dynamic PET imaging requires metabolite-corrected arterial input functions, traditionally obtained through invasive arterial blood sampling, limiting broader adoption of quantitative kinetic modelling. Achieving generalisability across datasets, scanners, and imaging centres remains a major challenge for data-driven alternatives. METHODS: We developed ASTRA, a deep-learning-based framework for arterial input function estimation from dynamic brain TSPO PET. ASTRA was developed and validated using arterial measurements in one dataset (n=90), then transfer-learned and evaluated against arterial measurements at a second centre (n=52). Building upon this, ASTRA was applied to an independent clinical cohort (n=32) from the second site but without arterial reference data, where quantitative analyses had therefore not been performed, to assess whether it could reproduce previously reported semi-quantitative cross-sectional group differences. Robustness to altered tracer kinetics was evaluated in an out-of-distribution pharmacological blockade cohort (n=5). RESULTS: ASTRA-derived quantitative estimates agreed with arterial measurements (VT: CCC=0.658-0.805), with higher uncertainty associated with greater error. In the clinical cohort, ASTRA reproduced SUVR-based group differences using DVR (p<0.001), except in the pituitary gland (p=0.12). Finally, ASTRA yielded receptor occupancy estimates (0.92±0.17) closely matching arterial values (0.94±0.12) in the blocking cohort. CONCLUSION: These findings demonstrate the feasibility of multi-site, non-invasive quantitative TSPO PET.
No takes yet. Share an insight, caveat, or question.
Brusaferri et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: